Navigation Links
U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
Date:5/6/2010

WAYNE, N.J., May 6 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Natazia™ (estradiol valerate and estradiol valerate/dienogest) tablets for the prevention of pregnancy.  Natazia has not been evaluated in women with a BMI of greater than 30 kg/m(2).  Natazia is the first and only oral contraceptive that contains an estrogen called estradiol valerate and a progestin called dienogest.  Estradiol valerate is a synthetic estrogen that is converted to estradiol in a woman's body.  Natazia is expected to be available in the summer.

Until today, all marketed combination oral contraceptives (COCs) contained ethinyl estradiol.  With the FDA approval of Natazia, Bayer HealthCare Pharmaceuticals becomes the first company to launch estradiol valerate together with the progestin, dienogest.

"Every woman's body reacts differently to hormones, so it is important that they have a choice in birth control options," said Anita Nelson, MD, professor of obstetrics and gynecology at the Harbor-UCLA Medical Center, Torrance, California.  "Natazia may be a good option for women to consider when making a decision with their healthcare provider about which birth control option is right for them."

Women using COCs, including Natazia, should be strongly advised not to smoke.  Smoking increases the risk of serious cardiovascular side effects from COC use.  The risk increases with age and the number of cigarettes, especially in women over 35 years old.

Natazia is taken once a day.  The dosing regimen consists of pills with varying doses of estradiol valerate, and estradiol valerate in combinati
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves New Combination Product Oral Contraceptive
2. FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
3. FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
4. FDA Approves New Device for Adults with Severe and Persistent Asthma
5. FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels
6. FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
7. FDA Approves First Totally Implanted Hearing System
8. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
9. FDA Approves Name Change for Heartburn Drug Kapidex
10. FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland
11. FDA Approves First New Inhaled Antibiotic for CF in More Than a Decade
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)...   EVO Aesthetic Center and Wellness Spa ... aesthetics in Lakeway, Texas and ... Astanza Duality laser. The medical spa is focused on ... and laser procedures. Their addition of the Astanza Duality ... to their tattoo regret. "The large number ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 ... of assets related to the ion channel biology platform ... previously been obtained as part of Pfizer,s 2011 acquisition ... Pfizer,s rights to the "Icagen" name and trademark.  XRPro ... comprehensive services for ion channel and transporter drug discovery, ...
(Date:7/2/2015)... , 2 de julio de 2015 ... ADN de alto rendimiento en ... American College of Pathologists (CAP). La instalación de BGI en ... laboratorio de secuenciación de próxima generación que recibe la ... el más alto estándar en prácticas de laboratorio clínico. ...
Breaking Medicine Technology:EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4BGI recibe la acreditación del College of American Pathologists (CAP) 2
(Date:7/4/2015)... ... July 04, 2015 , ... Chronic Neck Pain. Neck pain is ... located in the neck. Another 19% suffer from head, migraine, or facial pain, in ... that 45% of American workers must deal with neck pain. Strategies for ...
(Date:7/3/2015)... ... July 03, 2015 , ... On June ... a new SEO training system called "Page One Engine" . The program, ... has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. ... been retained to lead a national chief nursing officer recruitment for ... firms in the healthcare industry, B. E. Smith has recently placed more than ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... First ... United States, named Mariah N. Manzanares, MD as the new Medical Director of its ... facility medical director of our Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:7/2/2015)... , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. ... The opening is the first sweetFrog store located in Mississippi. The premium frozen yogurt ... in 2014. , The store, located at 104 Railroad Avenue, New Albany, MS 38652, ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2
... News) -- Over the last decade, the number of ... a smaller slice of the 10-year hospitalization rate than ... finding stems from the largest effort launched in the ... patterns. In the latest year, Medicare hospitalizations totaled about ...
... University of Houston (UH) students, two from the ... College of Social Work (GCSW), will lead health-related ... 2011-2012 under the Houston-Galveston Schweitzer Fellows Program. ... program sites throughout the U.S., the newly selected ...
... Calif. Evolutionary geneticist John H. Werren will give ... Riverside on Monday, May 16. His lecture, titled "Using ... speciation," will take place at 4 p.m. in the Genomics Auditorium, ... 5 p.m. in the Department of Entomology lobby. Both ...
... (HealthDay News) -- ,Bedbugs carrying two types of drug-resistant ... discovery in light of the resurgence of bedbugs in ... years. The researchers tested five bedbugs collected from ... Columbia known as Downtown Eastside, which has high rates ...
... News) -- The flakes of human skin in household dust ... Humans shed their entire outer layer of skin every ... study, published in the May issue of the journal ... oils such as cholesterol and squalene, are a major contributor ...
... exercise all have received their fair share of blame for ... to a University of Illinois researcher, public health enemy No. ... one staple of modern life most Americans can,t seem to ... Jacobson, a professor of computer science and the director of ...
Cached Medicine News:Health News:Fewer Medicare Patients Hospitalized for Heart Trouble 2Health News:3 University of Houston students chosen as Albert Schweitzer Fellows 2Health News:Evolutionary geneticist to give talk at UC Riverside on how biological species evolve and adapt 2Health News:Bedbugs May Transmit Drug-Resistant Bacteria 2Health News:Shed Skin in Dust May Reduce Indoor Air Pollution 2Health News:Study: Surge in obesity correlates with increased automobile usage 2Health News:Study: Surge in obesity correlates with increased automobile usage 3Health News:Study: Surge in obesity correlates with increased automobile usage 4
Multi-constituent Calibration Plasma for Functional Assays of Coagulation Parameters on STA© Analyzers....
Multi-constituent normal and abnormal plasma controls for routine and specialty assays performed on the STA© family of hemostasis analyzers....
... Normal and Abnormal Control ... of vWF, D-dimer and ... STA© Analyzers. For use ... (#0518),STA© LIATEST© D-DI (#0515) ...
ApolipoproteinA-1 & B Calibrator...
Medicine Products: